Navigation Links
Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform
Date:6/28/2011

RESTON, Va., June 28, 2011 /PRNewswire/ -- The Mirixa Corporation and the Canadian Association of Chain Drug Stores (CACDS) are pleased to announce that MirixaPro(SM), a Web-based clinical platform that supports and documents standardized, pharmacy-based patient care service delivery, will be deployed in Canada. The two organizations signed a 10-year licensing agreement enabling CACDS to use a scalable, localized version of the MirixaPro platform.

(Logo:  http://photos.prnewswire.com/prnh/20100818/SF51721LOGO)

CACDS members represent more than 6,200 pharmacies and dispense 70% of Canada's prescriptions each year. The deployment of MirixaPro will enable Canada's most active pharmacies to more efficiently augment their dispensing services with enhanced pharmacy services including comprehensive medication management. MirixaPro will enable pharmacists to document patient progress, identify compliance issues, and supply educational materials. This information can then be shared with patients' other care providers, fostering greater care and inter-professional collaboration and ultimately optimizing health outcomes.

Nadine Saby, President and CEO of CACDS comments, "Community pharmacy in Canada is in the early stages of significant professional practice evolution and payers are moving to establish reimbursement for these new pharmacy services, recognizing the value in improved patient health and well-being and cost effectiveness to the health care system. To better enable the delivery of these services, CACDS looked for a tool that would help standardize the deployment of clinical pharmacy services across the country through the use of a common technology platform. We evaluated a number of solutions and were impressed with the strength of the MirixaPro platform and the robustness of its capabilities."

"Worldwide, patient engagement is considered a necessary component for improved patient health outcomes," notes Rick Solano, CEO of Mirixa. "We are delighted that MirixaPro will be an important vehicle used by Canadian pharmacists to actively engage their patients and expand the role of pharmacists within their communities. Our deployment of technology beyond the U.S. demonstrated to CACDS leadership that the MirixaPro platform could be adapted to local needs and support an expanded set of requirements well into the future."

About Mirixa Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the health care community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit www.Mirixa.com.

About CACDS CACDS is the national association that represents the community pharmacy industry in Canada. The retail members of CACDS are traditional chain and banner drug stores, grocery chains and mass merchandisers with pharmacies. CACDS associate members include companies representing all product categories and service suppliers to the drug store industry.

CACDS provides its members with a wide range of services, including authoritative research and discussion forums on industry trends, representation of industry viewpoints to governments, stakeholders and the public, and co-operative initiatives with related industry sectors - all in the interest of enhancing the value of community pharmacy to consumers. Visit online at www.cacds.com Media Contacts: Mirixa:

Anne Marie Heil 703.865.2035 amheil@Mirixa.com CACDS:

Sara Feldman 416.226.9100 x225 sfeldman@cacds.com
'/>"/>

SOURCE Mirixa Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC
2. Kerr Drug to Deploy Mirixa Technology for Clinical Services
3. Mirixa Australia Achieves Six Month Milestones
4. Mirixa Corporation Announces MirixaEdge(SM)
5. Mirixa Corporation Announces Key Pharmacy Network Hire
6. Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed-Dose Combination of PREZISTA® and Cobicistat
7. Accuray Hosts Korean Embassys Minister for Economic Affairs at Event to Support the U.S.-Korea Free Trade Agreement
8. SpaCapsule Manufacturer Delivers First Order to Elements Diet and Fitness Under Preferred Vendor Agreement
9. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
10. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit
11. Still River Systems Sign Patent License Agreement With the Massachusetts Institute of Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):